Mobile Technology to Assist Patient Education and Research in Arthroplasty
- Conditions
- Total Knee ReplacementTotal Hip ReplacementMusculoskeletal - OsteoarthritisMusculoskeletal - Other muscular and skeletal disordersSurgery - Other surgery
- Registration Number
- ACTRN12620001067965
- Lead Sponsor
- Medacta Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Patients 18 years or over presenting with hip or knee arthritis that meets the indications for hip or knee arthroplasty respectively
- Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery
- Patients who are considered by the surgeon to be capable of following the patient optimised pathway
- Patients under the age of 18 years
- Patients with one or more medical conditions identified as a contraindication defined by the labelling on any Medacta implants used in this study
- Any patient who cannot or will not provide informed consent for participation in the study
- Patients who need revision surgery
- Patients unable to communicate in English
- Any case not described in the inclusion criteria
- Patients who do not own a compatible smartphone
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient satisfaction with the mobile phone application (app) in delivering information on their treatment program, rehabilitation and research tools.<br>This is assessed by patient completion of study-specific patient satisfaction survey delivered via the app.[Baseline (pre-surgery), Day 1, 2 weeks, 6 weeks, 3 months and 6 months post-surgery.]
- Secondary Outcome Measures
Name Time Method